Back to today’s briefing

Story perspectives

Glyphosate Scrutiny Intensifies Amid Lawsuit Protections for Bayer

5/20/2025

39 3

Summary

Story summary

Glyphosate, a controversial herbicide tied to cancer risks, is under intense examination in the U.S. and Europe. Bayer has already paid over $14 billion in lawsuits, yet North Dakota's new laws may protect the company from future claims. Meanwhile, Health Secretary Robert F. Kennedy Jr. is set to spotlight glyphosate, stirring unease among farmers and regulators alike.

1 of 1

Story summary

Glyphosate, a controversial herbicide tied to cancer risks, is under intense examination in the U.S. and Europe. Bayer has already paid over $14 billion in lawsuits, yet North Dakota's new laws may protect the company from future claims. Meanwhile, Health Secretary Robert F. Kennedy Jr. is set to spotlight glyphosate, stirring unease among farmers and regulators alike.